— Know what they know.
Not Investment Advice

BNIGF OTC

Beroni Group Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.9% 5Y: -99.2%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 38 · $212760 mcap · 59173 float · 0.039% daily turnover

Balance Sheet Trends

Total Assets
$7M -26.1% ▼
5Y CAGR: -12.9%
Total Liabilities
$4M -63.7% ▼
5Y CAGR: +16.6%
Shareholders Equity
$4M +2504.3% ▲
5Y CAGR: -21.9%
Cash & Investments
$2M -55.9% ▼
5Y CAGR: -10.0%
Total Debt
$2M -68.5% ▼
5Y CAGR: +6.6%
Net Debt
-$254K -131.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$5M$6M$3M$4M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$5M$6M$3M$4M$2M
Net Receivables$1M$2M$2M$327K$151K
Inventory$113K$316K$294K$104K$64K
Other Current Assets$0$158K$0$286K$330K
Total Current Assets$6M$8M$5M$6M$3M
Property, Plant & Equip.$696K$384K$2M$1M$999K
Goodwill & Intangibles$3M$3M$3M$2M$2M
Long-Term Investments$1M$0$0$0$0
Other Non-Current Assets$47K$51K$50K$1M$955K
Total Non-Current Assets$5M$4M$5M$4M$4M
Total Assets$12M$12M$10M$10M$7M
— Liabilities —
Accounts Payable$19K$22K$588K$384K$143K
Short-Term Debt$3M$3M$726K$4M$1M
Deferred Revenue$35K$87K$0$0$0
Other Current Liabilities$926K$346K$181K$4M$1M
Total Current Liabilities$4M$4M$2M$10M$3M
Long-Term Debt$0$0$0$138K$0
Other Non-Current Liab.$7K$0$0$16K$0
Total Non-Current Liabilities$289K$34K$515K$502K$373K
Total Liabilities$2M$4M$3M$10M$4M
— Equity —
Common Stock$27M$31M$31M$33M$50M
Retained Earnings-$21M-$23M-$31M-$42M-$53M
Accumulated OCI$432K$275K$7M$7M$7M
Total Stockholders Equity$7M$8M$7M-$161K$4M
Total Liabilities & Equity$12M$12M$10M$10M$7M
— Key Metrics —
Total Debt$3M$3M$2M$5M$2M
Net Debt-$4M-$3M-$1M$816K-$254K
Total Investments$1M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms